Infections in cirrhosis, Curr Treat Options Gastroenterol, vol.17, pp.254-70, 2019. ,
Resistant bacterial infections in cirrhosis: a French observational prospective multicentre nationwide study (RESIST study), J Hepatol, vol.66, pp.131-133, 2017. ,
,
, Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis, Gastroenterology, vol.139, pp.1246-1256, 2010.
Management of bacterial infections in cirrhosis, J Hepatol, vol.56, pp.1-12, 2012. ,
The impact of bacterial infections on survival of patients with decompensated cirrhosis, Ann Hepatol, vol.13, pp.7-19, 2014. ,
Physician clinical Impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis, Ann Emerg Med, vol.52, pp.268-73, 2008. ,
Clinical impression and ascites appearance do not rule out bacterial peritonitis, J Emerg Med, vol.44, pp.903-912, 2013. ,
, StatPearls [Internet, 2019.
Procalcitonin and liver disease: a literature review, J Clin Transl Hepatol, vol.7, pp.51-56, 2019. ,
Ascitic fluid calprotectin and serum procalcitonin as accurate diagnostic markers for spontaneous bacterial peritonitis, Gut Liver, vol.10, pp.624-655, 2016. ,
The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis, Clin Microbiol Infect, vol.21, pp.474-81, 2015. ,
,
, Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective 16 study, Hepatology, vol.55, pp.1551-61, 2012.
Cirrhotic patients are at risk for health care-associated bacterial infections, Clin Gastroenterol Hepatol, vol.8, pp.979-985, 2010. ,
Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver, J Lab Clin Med, vol.146, pp.347-51, 2005. ,
Serum procalcitonin in cirrhotic patients with sepsis, Chin J Hepatol, vol.23, pp.428-460, 2015. ,
C-reactive protein and bacterial infection in cirrhosis, Ann Gastroenterol, vol.27, pp.113-133, 2014. ,
Usefulness of procalcitonin for diagnosing infection in critically ill patients with liver cirrhosis, Med Intensiva Engl Ed, vol.40, pp.84-93, 2016. ,
The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and noncirrhotic patients, Int J Med Sci, vol.10, pp.1367-1374, 2013. ,
Serum procalcitonin and Creactive protein levels as markers of bacterial infection: a systematic review and metaanalysis, Clinical Infectious Diseases, vol.39, pp.206-217, 2004. ,
Procalcitonin is a valid marker of infection in decompensated cirrhosis, Zeitschrift für Gastroenterologie, vol.41, pp.165-70, 2003. ,
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis, Diagn Microbiol Infect Dis, vol.80, pp.72-80, 2014. ,
The diagnostic and prognostic values of C-Reactive Protein and procalcitonin during bacterial infections in decompensated cirrhosis, Gastroenterology Research and Practice, pp.1-6, 2018. ,
Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease, Medicine, p.2016 ,
,
, Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease, Eur J Gastroenterol Hepatol, vol.18, pp.525-555, 2006.
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis, Semin Liver Dis, vol.28, pp.26-42, 2008. ,
The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome, J Hepatol, vol.51, pp.475-82, 2009. ,
Prevention and management of bacterial infections in cirrhosis, Int J Hepatol, p.784540, 2011. ,
Antibiotic prophylaxis in cirrhosis: Good and bad, Hepatology, vol.63, pp.2019-2050, 2016. ,
Use of rifaximin in gastrointestinal and liver diseases, World J Gastroenterol, vol.22, pp.6638-51, 2016. ,
Rifaximin: a potential alternative to prevent bacterial infection in cirrhotic patient?, J Afr Hepato-Gastroenterol, vol.9, pp.122-128, 2015. ,
The impact of rifaximin in the prevention of bacterial infections in cirrhosis, Eur Rev Med Pharmacol Sci, vol.21, pp.1151-1158, 2017. ,
,
, Impact of Rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites, PLoS ONE, vol.9, 2014.
,
, Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, vol.69, pp.406-60, 2018.
New prognostic markers in liver cirrhosis, World J Hepatol, vol.7, pp.1244-50, 2015. ,
Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?, Dig Liver Dis, p.0, 2019. ,
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients, BMC Infect Dis, vol.18, 2018. ,
Infection and alcoholic liver disease, Clin Liver Dis, vol.20, pp.595-606, 2016. ,
Alcohol's effect on host defense, Alcohol Res Curr Rev, vol.37, pp.159-70, 2015. ,
Utility of initial procalcitonin values to predict urinary tract infection, Am J Emerg Med, vol.36, 1993. ,